NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

That was one thing that Les did say on that show.
Words to the effect of;- we can treat patients compassionately in the UK and we can get paid for that.
I know we basically knew that already, but it's just a bit of extra confirmation, if it were needed.

Now we could do with knowing whether Covid restrictions have lifted sufficiently to allow treatment under UK Specials to resume. As the 10-Q strongly suggested that Covid had effectively halted the programme.
I think your revenue estimate is a bit on the optimistic side, but obviously every bit of earned revenue helps.

It would be nice to know how close we are to a licensed Sawston. And that licensing process might be subject to Covid delay.
I think working out of Sawston would enable UK Specials numbers to go from very small to just small, with a corresponding increase in the revenue stream.

And treatment outcomes from UK Specials would also be very interesting, because they may be treating a wider range of patients than in the trial. Maybe rGBM, maybe other types of glioma, and maybe upfront DCVax-L in some case without chemorad beforehand.
All of which could provide them with additional insights into what works best.
Though I doubt we will actually get any such outcome data.
But you never know.